AU2004904403A0 - Alkyl, Alkylene, Alkyline, Aryl-dioxy amphetamine and dopamines and substituted catecholamines and its derivatives for the treatment of Parkinson's disease
- Google Patents
Alkyl, Alkylene, Alkyline, Aryl-dioxy amphetamine and dopamines and substituted catecholamines and its derivatives for the treatment of Parkinson's disease
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2004904403A
Inventor
John Jakos Gyuran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gyuran Laboratory And Consulting Div Of 925186 Out Inc
HUNOR PHARMACEUTICALS Inc
Original Assignee
Gyuran Laboratory And Consulting Div Of 925186 Out Inc
HUNOR PHARMACEUTICALS Inc
Filing date
Publication date
Application filed by Gyuran Laboratory And Consulting Div Of 925186 Out Inc, HUNOR PHARMACEUTICALS IncfiledCriticalGyuran Laboratory And Consulting Div Of 925186 Out Inc
Publication of AU2004904403A0publicationCriticalpatent/AU2004904403A0/en
AU2004904403A2004-08-06Alkyl, Alkylene, Alkyline, Aryl-dioxy amphetamine and dopamines and substituted catecholamines and its derivatives for the treatment of Parkinson's disease
AbandonedAU2004904403A0
(en)
Novel 1,4-benzothiazepine-1,1-dioxide, derivative having improved properties, method for the production thereof, medicaments containing said compound, and use thereof
Alkyl, Alkylene, Alkyline, Aryl-dioxy amphetamine and dopamines and substituted catecholamines and its derivatives for the treatment of Parkinson's disease
Alkyl, Alkylene, Alkyline, Aryldioxy amphetamines and Dopamines and substituted catecholamines and its derivatives for the treatment of Parkinson's disease
Alkyl, Alkylene, Alkyline, Aryl-dioxy amphetamines and dopamines and substituted catecholamines and its derivatives for the treatment of Parkinson's disease
Alkyl, alkylene, alkyline, aryl-dioxy amphetamines and dopamines and subst ituted catecholamines and its derivatives for the treatment of parkinson's disease